Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03998189 · ClinicalTrials.gov registry record · NA
Metabolic and Microbial Profiling of Lung Cancer
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03998189: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT03998189 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03998189, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This pilot study will establish non-invasive sample collections, including breath, saliva, blood and urine pre-surgery and at the participant's one-month post-surgery follow-up visit. Participants with suspected non-small cell lung cancer (NSCLC) stage I-III will be recruited.
Primary Outcome
The primary objectives is to assess the feasibility of adding these non-invasive sample collections to pre- and post-surgery visits the following outcomes (counts) will be gathered - (number eligible for trial, number that consent to participate, number that provide pre-surgery samples, number that provide post-surgery samples) using a 95% exact Clopper-Pearson confidence interval for each feasibility estimate.
Interventions
- OTHER Urine Collection
- OTHER Blood Collection
- OTHER Saliva Collection
- OTHER Breath Collection
- OTHER Tumor Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2021-06-21 |
| Phase | NA |
Why NCT03998189 stopped before completion
NCT03998189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Urine Collection is the first listed.
NCT03998189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03998189 about?
NCT03998189 is a clinical study titled "Metabolic and Microbial Profiling of Lung Cancer". This pilot study will establish non-invasive sample collections, including breath, saliva, blood and urine pre-surgery and at the participant's one-month post-surgery follow-up visit. Participants with suspected non-small cell lung cancer (NSCLC) stage I-III will be recruited.
What is the current status of trial NCT03998189?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-10-11. Estimated completion is 2021-06-21.
What interventions are being tested in trial NCT03998189?
The interventions under investigation include: Urine Collection (OTHER), Blood Collection (OTHER), Saliva Collection (OTHER), Breath Collection (OTHER), Tumor Collection (OTHER).
Who is sponsoring clinical trial NCT03998189?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03998189's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI